Showing 1 - 5 results of 5 for search 'Özgür Pektaş', query time: 0.03s Refine Results
  1. 1
    Otojen iliak kemikle greftlenen atrofik maksillanın 4 implant üstü zirkonyum sabit protezle rekonstrüksiyonu: Olgu sunumu

    Otojen iliak kemikle greftlenen atrofik maksillanın 4 implant üstü zirkonyum sabit protezle rekonstrüksiyonu: Olgu sunumu by Yusuf Tamer, Deniz Somay, Zafer Özgür Pektaş

    Published 2017-07-01
    Get full text
    Article
  2. 2
    Evaluation of the Changes associated with Bone-Anchored Pendulum Appliance after the Completion of Comprehensive Orthodontic Treatment

    Evaluation of the Changes associated with Bone-Anchored Pendulum Appliance after the Completion of Comprehensive Orthodontic Treatment by Beyza Hancıoğlu-Kırcelli, Zafer Özgür Pektaş, Sevinç Karan, Ömür Polatözsoy

    Published 2008-04-01
    Get full text
    Article
  3. 3
    REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY

    REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY by Ozgur Pektas, Prakash Navaratnam, Tanvi Rajput, Howard S. Frıedman, Ece Demırkır, Christina Tekle, Peggy Lın

    Published 2023-10-01
    Get full text
    Article
  4. 4
    UPDATED PROGRESSION-FREE SURVIVAL (PFS) AND DEPTH OF RESPONSE IN IKEMA, A RANDOMIZED PHASE 3 TRIAL OF ISATUXIMAB, CARFILZOMIB AND DEXAMETHASONE (ISA-KD) VS KD IN RELAPSED MULTIPLE MYELOMA (MM)

    UPDATED PROGRESSION-FREE SURVIVAL (PFS) AND DEPTH OF RESPONSE IN IKEMA, A RANDOMIZED PHASE 3 TRIAL OF ISATUXIMAB, CARFILZOMIB AND DEXAMETHASONE (ISA-KD) VS KD IN RELAPSED MULTIPLE... by Ozgur PEKTAS, Philippe MOREAU, Meletios-Athanasios DIMOPOULOS, Joseph MIKHAEL, Kwee YONG, Marcelo CAPRA, Thierry FACON, Roman HAJEK, Ivan ŠPIČKA, France CASCA, Sandrine MACÉ, Marie-Laure RISSE, Thomas MARTIN

    Published 2022-10-01
    Get full text
    Article
  5. 5
    LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY

    LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY by Özgür Pektaş, Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knöbl, Flora Peyvandi, Spero Cataland, Paul Coppo, Johanna A. Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Sriya Gunawardena, Julie Lin

    Published 2022-10-01
    Get full text
    Article

Search Tools: